Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii

Antimicrob Agents Chemother. 1996 Apr;40(4):870-3. doi: 10.1128/AAC.40.4.870.

Abstract

We report the sequence of the quinolone resistance-determining region of the gyrA genes of either susceptible or low-level-resistant clinical isolates of Coxiella burnetii. The sequences of low-level (MICs, 4 micrograms/ml) and high-level (MICs, 8 and 16 micrograms/ml) resistant strains stepwise selected in vitro were also determined. The gene sequences of all of the clinical isolates and that of the in vitro-selected low-level-resistant strain were identical. Sequence analysis of the in vitro-selected high-level-resistant strain revealed a nucleotide mutation leading to an amino acid substitution of Gly in place of Glu at position 87 of the GyrA amino acid sequence. These results indicate that high-level resistance to ciprofloxacin is associated with a nucleotide mutation in gyrA, whereas low-level resistance to quinolones is not.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Infective Agents / pharmacology*
  • Base Sequence
  • Ciprofloxacin / pharmacology*
  • Coxiella burnetii / drug effects*
  • Coxiella burnetii / genetics*
  • DNA Gyrase
  • DNA Topoisomerases, Type II / genetics*
  • Drug Resistance, Microbial
  • Humans
  • Molecular Sequence Data

Substances

  • Anti-Infective Agents
  • Ciprofloxacin
  • DNA Gyrase
  • DNA Topoisomerases, Type II

Associated data

  • GENBANK/S82903